Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof
Details for Australian Patent Application No. 2005320472 (hide)
International Classifications
Event Publications
26 July 2007 PCT application entered the National Phase
PCT publication WO2006/071017 Priority application(s): WO2006/071017
26 February 2009 Application Accepted
Published as AU-B-2005320472
25 June 2009 Standard Patent Sealed
27 January 2011 Assignment Registered
Hanmi Pharm. Co., Ltd. The patent has been assigned to Hanmi Holdings Co., Ltd.
30 August 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Hanmi Science Co., Ltd. . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000 2006
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005320475-A electric home appliance able to power line communication
2005320451-Scheduling apparatus and method in a multicarrier communication system
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser